Synopsis
In hit finding for chemical probe and drug discovery, a screen is only as good at the molecules that go into it. With the vast potential chemical space, how do you decide what to include in your virtual, high-throughput, or fragment-based screen? The 1-day symposium, 鈥淚nnovation in Design and Acquisition for Compound Screening Libraries,鈥� seeks to explore this question and create a dynamic, interactive environment for discussion of this important topic. In this ever-evolving area, it is critical to understand the current design and selection methods of compound screening libraries, along with the range of available business models for library acquisition and enhancement. The conference should appeal to medicinal chemists, synthetic chemists, computational chemists and compound management teams from industry and academia involved in library design and acquisition along with those involved in hit and lead generation primarily in drug discovery and agrochemistry. Presentations from industry, academia and commercial compound vendors will include talks on computational design, focused library sets for phenotypic screening, 3-d fragment libraries, attention to physicochemical properties, opportunities from advances in synthetic organic chemistry as well as the compound acquisition market place. In addition, there will be ample opportunities for discussion and networking
whilst browsing trade stands from the leading library suppliers.
Attendees
This meeting will be of interest to scientists interested in early stage drug discovery and screening, Medicinal Chemists, Computational Chemists, Compound Management Chemists, those working in Chemical Procurement, academics and students.
SCI Members attending this meeting are able to claim CPD points.
In hit finding for chemical probe and drug discovery, a screen is only as good at the molecules that go into it. With the vast potential chemical space, how do you decide what to include in your virtual, high-throughput, or fragment-based screen? The 1-day symposium, 鈥淚nnovation in Design and Acquisition for Compound Screening Libraries,鈥� seeks to explore this question and create a dynamic, interactive environment for discussion of this important topic. In this ever-evolving area, it is critical to understand the current design and selection methods of compound screening libraries, along with the range of available business models for library acquisition and enhancement. The conference should appeal to medicinal chemists, synthetic chemists, computational chemists and compound management teams from industry and academia involved in library design and acquisition along with those involved in hit and lead generation primarily in drug discovery and agrochemistry. Presentations from industry, academia and commercial compound vendors will include talks on computational design, focused library sets for phenotypic screening, 3-d fragment libraries, attention to physicochemical properties, opportunities from advances in synthetic organic chemistry as well as the compound acquisition market place. In addition, there will be ample opportunities for discussion and networking
whilst browsing trade stands from the leading library suppliers.
Attendees
This meeting will be of interest to scientists interested in early stage drug discovery and screening, Medicinal Chemists, Computational Chemists, Compound Management Chemists, those working in Chemical Procurement, academics and students.
SCI Members attending this meeting are able to claim CPD points.
